An advanced bone graft substitute combining silicate calcium phosphate with growth factors to promote bone formation.
ACTIFUSE is a clinically-proven osteoinductive product designed to enhance fusion rates and accelerate bone healing in orthopedic procedures. Its unique formulation supports rapid vascularization and bone integration, making it an effective alternative to traditional bone grafting methods.
Bone tissue harvested from a human donor and processed for use in another patient's surgical procedure.
Allografts are cadaveric bone products that provide structural support and some biological benefits but carry risks of disease transmission and may require additional processing. Modern bone graft substitutes like those offered by Elite Surgical provide safer, more consistent alternatives while maintaining superior clinical performance.
A porous bone graft substitute engineered to support bone ingrowth and structural stability.
ALTAPORE is designed with a highly porous architecture that facilitates cellular infiltration and new bone formation within the graft material. Its structural properties provide immediate mechanical support while promoting long-term biological integration and fusion success.
Bone tissue harvested from a patient's own body and transplanted to another site within the same patient.
Autografts are considered the gold standard for bone grafting due to their biological properties and low rejection risk, but they require a second surgical site for harvest, increasing morbidity and operative time. Advanced bone graft substitutes offer comparable or superior results without the complications associated with donor site harvesting.
The ability of a material to function within the body without triggering adverse immune or inflammatory responses.
Biocompatible bone graft substitutes are engineered to integrate seamlessly with host bone tissue while minimizing rejection and inflammatory reactions. This property is essential for ensuring patient safety, promoting successful fusion, and achieving optimal surgical outcomes.
A biocompatible material engineered to replace or augment natural bone in surgical procedures.
Bone graft substitutes are synthetic or processed materials designed to promote bone healing and fusion without requiring harvest from a donor site. These alternatives to autografts and allografts reduce patient morbidity while maintaining the biological and mechanical properties necessary for successful bone integration and regeneration.
The percentage of patients who achieve successful bony union between vertebrae or bones following a fusion procedure.
Fusion rate is a critical measure of surgical success, indicating the proportion of patients in whom the graft material successfully integrates and creates solid bone bridging between surgical sites. Higher fusion rates correlate with improved patient outcomes, reduced revision surgery rates, and better long-term clinical results.
Surgical procedures performed through small incisions using specialized instruments and visualization techniques.
Minimally invasive orthopedic procedures reduce tissue trauma, blood loss, and recovery time compared to open surgery. Advanced bone graft substitutes like ACTIFUSE and ALTAPORE are specifically designed to be compatible with these techniques, enabling surgeons to achieve excellent fusion outcomes through smaller incisions.
The capacity of a material to serve as a scaffold for bone cells to migrate, attach, and proliferate.
Osteoconductive materials provide a three-dimensional framework that guides bone growth along the implant surface without actively stimulating bone formation. This passive but essential property ensures that bone-forming cells can integrate the graft material into new bone tissue.
The ability of a material to stimulate bone-forming cells and promote new bone formation.
Osteoinductive bone graft substitutes contain biological signals or growth factors that recruit and activate osteoblasts, the cells responsible for bone formation. This property is critical for achieving successful fusion and is a key advantage of advanced graft materials over purely osteoconductive alternatives.
A surgical procedure that permanently joins two or more vertebrae to eliminate motion between them.
Spinal fusion is performed to stabilize the spine, reduce pain, and correct deformities caused by degenerative disc disease, trauma, or instability. The procedure involves placing bone graft material between vertebrae to promote bone growth and create a solid connection, often supported by hardware like screws and rods.
The process by which new blood vessels form and grow into a graft material to supply nutrients and oxygen.
Successful vascularization is critical for bone graft integration, as new blood vessels deliver oxygen, nutrients, and bone-forming cells to the graft site. Osteoinductive materials like ACTIFUSE are designed to promote rapid vascularization, accelerating bone formation and improving long-term fusion success.